Global Orthopedic Oncology Market Outlook 2025: Opportunity & Growth Analysis.

Market Overview

Evolution of advanced and precision oncology tends to drive the adoption of orthopaedic oncology in future whereas orthopaedic oncology represents a very small share in orthopaedic. Orthopaedic oncology tumors include Ewing sarcoma, osteosarcoma, and other malignancies which involve the musculoskeletal system. The majority of orthopaedic products are devices regulated by the Center for Devices and Radiological Health (CDRH) of the FDA where FDA does not regulate the practice of medicine directly. Instead, it regulates the claims that manufacturers can make regarding their orthopaedic devices. Each year around 600,000 fractures of the long bones of the legs and arms are stabilized by metal plates, nails, and screws in United States. Carbon fiber stuck together with epoxy resin showed some promise but also high infection rates in orthopaedic oncology, however, small company called CarboFix Orthopedics is helping revise hope and interest in carbon fiber orthopedic implants.

Goldstein Research analyst forecast the orthopaedic oncology market size is set to reach USD 1.23 billion by 2025, at a CAGR of 2.2% over the forecast years. Macroeconomic factors such as FDA approvals are expected to increase the adoption rate of orthopaedic oncology in the developed countries.

Orthopedic Oncology Market Segmentation

By Procedure Type

• Soft Tissue Excisions/Resections
• Limb Salvage Surgery
• Amputation
• Adjuvant Chemotherapy
• Reconstructive Surgery

By End User

• Multispecialty Hospitals
• Cancer Research Institutes

Based on Geography

• North America (U.S. & Canada) Orthopaedic Oncology Market {Market Share (%), Market Size (USD Billion)}
• Latin America (Brazil, Mexico, Argentina & Rest of Latin America) Orthopaedic Oncology Market {Market Share (%), Market Size (USD Billion)}
• Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) Orthopaedic Oncology Market {Market Share (%), Market Size (USD Billion)}
• Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) Orthopaedic Oncology Market {Market Share (%), Market Size (USD Billion)}
• Middle East & Africa (GCC, South Africa, North Africa, RoMEA) Orthopaedic Oncology Market {Market Share (%), Market Size (USD Billion)}

Market Share by Procedure & by Region

Based on procedure type, in 2017 reconstructive surgery held the largest share valued 37.5% in the global orthopedic oncology market owing to the innovation in the prosthetics and bone grafting techniques for the benefit of patients. The limb salvage surgery is expected to grow at a subtle rate i.e. 2.5% due to its cost effective nature while adjuvant chemotherapy segment tends to grow at steady rate. 

Based on geography, North America represented the largest market for orthopaedic oncology worldwide in 2017 with the market share valued 41% due to rise in the number of musculoskeletal and cancer related disorders. For instance, according to U.S. Department of Health and Human Services, the number of new bone and joint cancer cases was estimated to be 3,260 and 1,550 people were estimated to die of this disease in U.S. Asia Pacific is anticipated to showcase substantial growth of 2.44% in orthopaedic oncology market over the forecast period attributed to strong growth in the development of healthcare infrastructure and rapid ageing old age population coupled with increasing cases of soft tissues and bones tumor. Whereas Middle East & Africa and Latin America tends to show the steady growth in global orthopaedic oncology market.

Trends, Drivers & Challenges to Market Growth

According to our global market study on the basis of extensive primary and secondary research: “One trend is the use of carbon-fiber-reinforced composite implants in orthopedic surgery as carbon-fiber-reinforced polyetheretherketone implants offer several benefits over traditional metal implants, lower modulus of elasticity better matches that of bone and their radiolucent property permits improved, artifact-free radiographic imaging.”

According to the report, major driving factor is the revolution of orthopaedic devices manufacturing through 3D printing which is technically called additive manufacturing where parts are built up layer-by-layer by adding to a workpiece using a variety of materials and energy sources to distinguish it from traditional machining, which “subtracts” material from a solid billet or from a rough part that was cast or forged and result in standard-sized implants or patient-specific implants.

Further, the report states the biggest challenge is the costly and complicated treatment therapies, in addition with lack of awareness about bone and musculoskeletal malignancies among the population are a major stumbling block for orthopaedic oncology market.

Covered in this Global Orthopaedic Oncology Market Report  

The report covers the present ground scenario and the future growth prospects of the orthopaedic oncology market for 2017-2025 along with the data of end user medical facilities worldwide. We calculated the market size and revenue share on the basis of revenue generated from major players across the globe. The Orthopaedic Oncology Market is forecasted on the basis of revenue analysis, product benchmarking and strategic developments of key market players. The report also includes micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Global Orthopaedic Oncology Market Outlook 2017-2025, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the global Orthopaedic Oncology Market. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Global Orthopaedic Oncology Market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.

Key Market Players

Our global Orthopaedic Oncology Market report comprises of the following companies as the key players.

•  Stryker Corporation
•  Amgen Inc.
•  Creganna Medical Group
•  Accentus Inc.
•  Canon Medical Systems
•  Siemens Healthineers
•  MD Anderson Cancer Center
•  F. Hoffmann-La Roche Ltd.
•  Novartis AG
•  Sanofi S.A.

 The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send here request for market report sample.

Intended Audience

• Orthopaedic Oncology devices (Implants, etc) Suppliers
• Orthopaedic Oncology devices manufacturers
• Research and Development (R&D) Companies
• Medical Research Laboratories
• Diagnostic centers
• Academic Medical Institutes and Universities

Key questions answered in this market study

• What is the total market size by 2025 and what would be the expected growth rate of market?
• What is the revenue of total market in 2016-17 and what would be the expected demand over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?

We can provide two hour complimentary interaction with our analyst after the purchase of this market report. Details are imparted within the report.